(309 days)
Not Found
No
The document describes a physical medical device (cervical fusion system) and its intended use, materials, and performance testing. There is no mention of software, algorithms, or any technology that would typically incorporate AI or ML.
Yes
The device is described as aiding in temporary stabilization and promoting bone fusion in patients with various spinal conditions, indicating a direct role in treating medical issues.
No
The device is a cervical fusion system, designed for temporary stabilization and promoting bone fusion during surgical correction of spinal disorders. It is a treatment device, not a diagnostic one.
No
The device description explicitly states it includes physical components like plates, screws, and interbody cages made of PEEK, which are hardware.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant system (plates, screws, and cages) for stabilizing the spine during fusion procedures. This is a therapeutic device, not a diagnostic one.
- Device Description: The description details the physical components of the implant system (materials, sizes, shapes). This aligns with a medical device used for treatment, not for analyzing samples from the body.
- Performance Studies: The performance studies focus on mechanical testing of the implant's strength and durability (compression, shear, subsidence, fatigue). This is relevant for a surgical implant, not for evaluating the accuracy of a diagnostic test.
- Lack of IVD Characteristics: There is no mention of analyzing biological samples (blood, urine, tissue, etc.), detecting specific analytes, or providing information for diagnosis.
In summary, the Carmen Cervical Fusion System is a surgical implant designed to treat spinal conditions, not to diagnose them.
N/A
Intended Use / Indications for Use
The Carmen plate and bone screw components are intended for anterior interbody screw fixation from C2-T1. The plate and bone screw components are indicated for use in the temporary stabilization of the anterior spine during the development of spinal fusions in patients with: 1) degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), 2) trauma (including fractures), 3) tumors, 4) deformity (defined as kyphosis, or scoliosis), 5) pseudoarthrosis, and/or 6) failed previous fusions.
Carmen anterior cervical cage component is intended to be used for anterior cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy with herniated disc and/or osteophyste formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. This cage is to be used in patients who have had six weeks of non-operative treatment. The Carmen™ cage must be used with supplemental fixation. The Carmen™ cage is also required to be used with autogenous bone graft comprised of cancellous and/or corticocancellous bone graft and is to be implanted via an open, anterior approach.
When used together, the Carmen components can be used only to treat cervical disc disease.
Product codes (comma separated list FDA assigned to the subject device)
ODP, KWQ
Device Description
Shanghai Sanyou Carmen™ Cervical Fusion System includes cervical plates and screws and interbody cages to stabilize and promote bone fusion during the normal healing process following surgical correction of disorders of the cervical spine. The interbody device is available in 2 widths (12 mm and 14 mm) and 4 heights (4, 5, 6 and 7 mm) and is composed of PEEK. The interbody device is offered with only one lordosis angle; each size is available with 7° lordosis. The plate is available in small or large with an integrated locking screw. The self-tapping screw is available in 3.5 or 4.0 mm diameter screws either 13 mm, 15 mm or 17 mm in length.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
anterior spine, C2-T1, C2-C3 disc to the C7-T1 disc
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Static and dynamic axial compression bending, static shear compression bending and subsidence testing were completed for the Shanghai Sanyou PEEK Cage System according the ASTM F2077-14, ASTM F2067-04, and Guidance for Industry and FDA Staff: Spinal System 510(k)s issued May 3, 2004. Plate dynamic compression testing was conduct according to ASTM F1717-15. Performance testing demonstrates that the subject device meets or exceeds performance of predicate devices demonstrating that the subject devices are substantially equivalent to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s): If the device was cleared using the 510(k) pathway, identify the Predicate Device(s) K/DEN number used to claim substantial equivalence and list them here in a comma separated list exactly as they appear in the text. List the primary predicate first in the list.
Reference Device(s): Identify the Reference Device(s) K/DEN number and list them here in a comma separated list exactly as they appear in the text.
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information for the subject device only (e.g. presence / absence, what scope was granted / cleared under the PCCP, any restrictions, etc).
Not Found
§ 888.3060 Spinal intervertebral body fixation orthosis.
(a)
Identification. A spinal intervertebral body fixation orthosis is a device intended to be implanted made of titanium. It consists of various vertebral plates that are punched into each of a series of vertebral bodies. An eye-type screw is inserted in a hole in the center of each of the plates. A braided cable is threaded through each eye-type screw. The cable is tightened with a tension device and it is fastened or crimped at each eye-type screw. The device is used to apply force to a series of vertebrae to correct “sway back,” scoliosis (lateral curvature of the spine), or other conditions.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features the department's name encircling a symbol. The symbol is a stylized representation of a human figure. The figure is composed of three overlapping profiles, suggesting a sense of community and care.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
October 5, 2017
Shanghai Sanyou Medical Co, Ltd % Christine Scifert Executive Vice President MRC-X, LLC 6075 Poplar Avenue, Suite 500 Memphis, Tennessee 38119
Re: K163366
Trade/Device Name: Shanghai Sanyou CARMEN Cervical Fusion System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral Body Fusion Device Regulatory Class: Class II Product Code: ODP, KWQ Dated: September 5, 2017 Received: September 6, 2017
Dear Ms. Scifert:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical devicerelated adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in
1
the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely,
Katherine D. Kavlock -S
for Mark N. Melkerson Director Division of Orthopedic Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K163366
Device Name
Shanghai Sanyou CARMEN Cervical Fusion System
Indications for Use (Describe)
The Carmen plate and bone screw components are intended for anterior interbody screw fixation from C2-T1. The plate and bone screw components are indicated for use in the temporary stabilization of the anterior spine during the development of spinal fusions in patients with: 1) degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), 2) trauma (including fractures), 3) tumors, 4) deformity (defined as kyphosis, or scoliosis), 5) pseudoarthrosis, and/or 6) failed previous fusions.
Carmen anterior cervical cage component is intended to be used for anterior cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy with herniated disc and/or osteophyste formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. This cage is to be used in patients who have had six weeks of non-operative treatment. The Carmen™ cage must be used with supplemental fixation. The Carmen™ cage is also required to be used with autogenous bone graft comprised of cancellous and/or corticocancellous bone graft and is to be implanted via an open, anterior approach.
When used together, the Carmen components can be used only to treat cervical disc disease.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff(@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
510(k) Summary
Shanghai Sanyou CARMEN Cervical Fusion System September 22, 2017
| Company: | Manufacturing Facility and Headquarters: |
|---|---|
| Shanghai Sanyou Medical Co, LTD | |
| 1988 Jiatang Road | |
| Jiading District, Shanghai, 201807, China | |
| Manufacturing Facility: | |
| Shanghai Sanyou Medical Co, LTD | |
| Rm 101/102/106/107 | |
| 356 Renqing Rd, Building 3-1F, | |
| Pudong New District, Shanghai 201201, China | |
| Primary Contact: | Christine Scifert |
| Phone: 901-831-8053 | |
| christine.scifert@mrc-x.com | |
| Company Contact: | David Fan, VP, Marketing |
| Phone: +86 21 58389980 | |
| Fax: +86 21 38682915 | |
| david.fan@sanyou-medical.com | |
| Trade Name: | Shanghai Sanyou CARMEN Cervical Fusion System |
| Common Name: | |
| Device | Spinal Intervertebral Body Fixation Orthosis, Intervertebal Body Fusion |
| Classification: | Class II |
| Regulation Number: | 21 CFR 888.3060 (Spinal Intervertebral Body Fixation Orthosis) |
| 21 CFR 888.3080 (Intervertebal Body Fusion Device) | |
| Panel: | 87- Orthopedic |
| Product Code: | KWQ, ODP |
4
Primary Predicate
Device:
K142450 – Medtronic Sofamor Danek, DIVERGENCE™ Anterior Cervical Fusion System
Additional Predicate
| Devices: | K100214 – Medtronic Sofamor Danek CORNERSTONE® PSR Spinal System |
|---|---|
| K131512 – Shanghai Sanyou, Katia Cervical Plate |
Device Description:
Shanghai Sanyou Carmen™ Cervical Fusion System includes cervical plates and screws and interbody cages to stabilize and promote bone fusion during the normal healing process following surgical correction of disorders of the cervical spine. The interbody device is available in 2 widths (12 mm and 14 mm) and 4 heights (4, 5, 6 and 7 mm) and is composed of PEEK. The interbody device is offered with only one lordosis angle; each size is available with 7° lordosis. The plate is available in small or large with an integrated locking screw. The self-tapping screw is available in 3.5 or 4.0 mm diameter screws either 13 mm, 15 mm or 17 mm in length.
Indications for Use:
The Carmen™ plate and bone screw components are intended for anterior interbody screw fixation from C2-Tl. The plate and bone screw components are indicated for use in the temporary stabilization of the anterior spine during the development of spinal fusions in patients with: 1) degenerative disc disease (as defined by neck pain of discogenic origin with degeneration of the disc confirmed by patient history and radiographic studies), 2) trauma (including fractures), 3) tumors, 4) deformity (defined as kyphosis, lordosis, or scoliosis), 5) pseudoarthrosis, and/or 6) failed previous fusions.
Carmen™ anterior cervical cage component is intended to be used for anterior cervical interbody fusion procedures in skeletally mature patients with cervical disc disease at one level from the C2-C3 disc to the C7-T1 disc. Cervical disc disease is defined as intractable radiculopathy and/or myelopathy with herniated disc and/or osteophyte formation on posterior vertebral endplates producing symptomatic nerve root and/or spinal cord compression confirmed by radiographic studies. This cage is to be used in patients who have had six weeks of non-operative treatment. The Carmen™ cage must be used with supplemental fixation. The Carmen™ cage is also required to be used with autogenous bone graft comprised of cancellous and/or corticocancellous bone graft and is to be implanted via an open, anterior approach.
When used together, the Carmen™ components can be used only to treat cervical disc disease.
5
Performance Testing:
Static and dynamic axial compression bending, static shear compression bending and subsidence testing were completed for the Shanghai Sanyou PEEK Cage System according the ASTM F2077-14, ASTM F2067-04, and Guidance for Industry and FDA Staff: Spinal System 510(k)s issued May 3, 2004. Plate dynamic compression testing was conduct according to ASTM F1717-15. Performance testing demonstrates that the subject device meets or exceeds performance of predicate devices demonstrating that the subject devices are substantially equivalent to the predicate devices.
Comparison of Technology:
The subject and primary predicate device (DIVERGENCE Anterior Cervical Fusion System) include a titanium alloy cervical plate component that mates with a PEEK interbody device. Additionally, the indications for use is the same for the subject device as the predicate device. The primary difference between the subject and predicate devices is the size range of plates and locking screws. The subject plate components range include a 16.5 mm and 18.5 mm plate with 13, 14 and 17 mm length locking screws. The predicate plate components have a larger range of sizes included 15.5-20.5 mm plates and 9-17 mm locking screws. Additionally, there are geometry differences between the subject and predicate devices. Mechanical testing demonstrates that the subject device is substantially equivalent to the predicate devices.
Substantial Equivalence:
The subject systems components are similar in sizes, materials and geometry to the predicate components. The subject components have the same indications as the predicate components. The difference in the subject and predicate devices do not rendered the system not substantially equivalent.
(Primary Predicate) K142450 – Medtronic Sofamor Danek, DIVERGENCE™ Anterior Cervical Fusion System
K100214 – Medtronic Sofamor Danek CORNERSTONE® PSR Spinal System
K131512 - Shanghai Sanyou, Katia Cervical Plate